Sumitomo Dainippon Pharma Co., Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sumitomo Dainippon Pharma Co., Ltd.
Public Company Edition: Roivant’s deal sets its market cap at $7.3bn. Beyond the Werewolf and Vaccitech offerings, more drug developers are slated to go public during the first week of May. And in follow-on offerings, COMPASS Pathways raises $144m and Aldeyra brings in $125m.
Novartis is trying its luck with capmatinib on the accelerated assessment front at the European Medicines Agency. Gilead and Astellas/Seagen have secured fast-track review for their respective potential new products while Sesen Bio and Amryt Pharma are dealing with rejection.
Kyorin, Eisai build on earlier OAB deal to team on vibegron. Plus deals involving Piramal/Hemmo, ImmuneOncia/3D Medicines, Kyowa Kirin/Cerecor, Simcere/Kazia, Nippon Shinyaku/Menarini, Tarsus/LianBio
Poxel’s potential first-in-class diabetes therapy, imeglimin, could be approved in Japan this year, and a new partner is being sought for the EU and US – events that would transform the outlook for the decade-old Merck Serono spin-out.
- Other Names / Subsidiaries
- Adagio Pharmaceuticals Ltd.
- Altavant Sciences
- Boston Biomedical, Inc.
- Boston Biomedical Pharma, Inc.
- Cannasat Therapeutics Inc.
- Cynapsus Therapeutics, Inc.
- Dainippon Sumitomo Pharma Co., Ltd.
- Dainippon Sumitomo Pharma Europe Ltd.
- DS Pharma Promo Co., Ltd,
- Elevation Pharmaceuticals, Inc.
- Enzyvant Therapeutics, Inc.
- Enzyvant Sciences, Ltd.
- Myovant Sciences Ltd
- Myovant Sciences GmbH
- Myovant Sciences, Inc.
- Oryx Pharmaceuticals Inc.
- SB Bioscience Co., Ltd.
- Spirovant Sciences
- Sumitomo Chemical Co., Ltd.
- Sumitomo Dainippon Pharma America, Inc. (formerly Dainippon Sumitomo Pharma America Holdings, Inc.)
- Sumitomo Dainippon Pharma Oncology, Inc.
- Sumitomo Pharmaceuticals America
- Sumitomo Pharmaceuticals (Suzhou) Co., Ltd.
- Sumitovant Biopharma
- Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.)
- Sunovion Pharmaceuticals Europe Ltd.
- Sunovion Respiratory Development Inc.
- Tolero Pharmaceuticals, Inc.
- Urovant Sciences, Inc.
- Sumitomo Pharmaceuticals Taiwan Co., Ltd.